copD - copper homeostasis membrane protein CopD Gene

Species: Leclercia adecarboxylata (strain: USDA-ARS-USMARC-60222, nat-host: Bos taurus)

Gene Type: protein coding
Gene ID: 30331974

copD Products (2)

mRNA Protein Name
WP_032611902.1 copper homeostasis membrane protein CopD [Leclercia adecarboxylata]
WP_032611902.1 copper homeostasis membrane protein CopD [Leclercia adecarboxylata]
Protein Preferred Names Protein Names

copper homeostasis membrane protein CopD

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (31)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-153192 Nerandomilast Inhibitor 99.99% Unkown
HY-B0809 Theophylline 99.97% Yes
HY-B1037 Salbutamol 99.53% Yes
HY-17585 Mepenzolate bromide 99.91% Unkown
HY-119708 Ensifentrine Inhibitor 99.36% Unkown
HY-B0436 Salbutamol hemisulfate 98.0% Yes
HY-14301 Olodaterol Agonist 99.85% Unkown
HY-14299 Indacaterol Agonist 99.98% Unkown
HY-D0205A Carbocisteine 98.0% Unkown
HY-B0330B Levofloxacin hydrochloride 99.99% Yes
HY-B0241 Ipratropium bromide Antagonist 99.92% Unkown
HY-14144 Aclidinium Bromide Antagonist 98.96% Unkown
HY-14301A Olodaterol hydrochloride Agonist 99.70% Unkown
HY-14299A Indacaterol maleate Agonist 99.82% Unkown
HY-B0944 Pidotimod Inhibitor 99.96% Unkown
HY-B0809R Theophylline (Standard) 99.99% Unkown
HY-B1675A Levalbuterol hydrochloride Agonist 99.58% Unkown
HY-B0004 Doxofylline 99.97% Yes
HY-103370 Talniflumate Inhibitor 99.90% Yes
HY-B0010D Arformoterol tartrate Agonist 99.63% Unkown
HY-108901 Formoterol hemifumarate hydrate Agonist 99.91% Unkown
HY-B0809A Theophylline monohydrate 99.93% Yes
HY-B1037R Salbutamol (Standard) 99.91% Unkown
HY-B1332 Ipratropium bromide hydrate Antagonist 99.90% Unkown
HY-137976 Penehyclidine hydrochloride 99.2% Unkown
HY-B0010A Arformoterol Agonist 99.96% Unkown
HY-B1675 Levalbuterol Agonist 99.79% Yes
HY-107909 Theophylline (sodium glycinate) / Unkown
HY-142119 Penehyclidine / Unkown
HY-B0809B Theophylline sodium acetate / Unkown
HY-B0010E Arformoterol maleate Agonist / Unkown
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9923 Benralizumab 99.1% Unkown

Clinical Phase

Bioactive Molecules (28)
Cat. No. Product Name Effect
Purity Phase
HY-14299D Indacaterol acetate Agonist / Phase 4
HY-14915 Bedoradrine / Phase 4
HY-B1037B Salbutamol adipate / Phase 4
HY-19519 Ladarixin Antagonist 99.95% Phase 3
HY-153192A Nerandomilast dihydrate Inhibitor 99.93% Phase 3
HY-10790 Cilomilast Inhibitor 99.91% Phase 3
HY-19519A Ladarixin sodium Antagonist 99.84% Phase 3
HY-105092 Tetomilast Inhibitor 98.15% Phase 3
HY-130786 Denbufylline Inhibitor 99.92% Phase 3
HY-135487 Sibenadet Agonist / Phase 3
HY-106448 Midesteine Inhibitor / Phase 3
HY-19644 GSK2256294A Inhibitor 99.84% Phase 2
HY-112726 PXS-4728A Inhibitor 98.79% Phase 2
HY-15545 AZD-4818 99.10% Phase 2
HY-109177 Icenticaftor Activator 99.66% Phase 2
HY-P3293A Lonodelestat TFA Inhibitor 98.20% Phase 2
HY-18862 PF-03715455 Inhibitor 98.44% Phase 2
HY-14298 Milveterol hydrochloride Agonist 99.04% Phase 2
HY-P3293 Lonodelestat Inhibitor 99.59% Phase 2
HY-19672 Lirimilast Inhibitor 98.69% Phase 2
HY-12463A Carmoterol Agonist 99.36% Phase 2
HY-106137 Tofimilast Inhibitor / Phase 2
HY-113692 AZD-9164 bromide Antagonist / Phase 2
HY-120802 Navafenterol / Phase 2
HY-120802A Navafenterol saccharinate / Phase 2
HY-19173 CE-1037 Inhibitor / Phase 2
HY-106996 AWD 12-281 Inhibitor 98.07% Phase 2
HY-108193 GW 328267 Agonist / Phase 1
Bioactive MoleculesInhibitory Antibodies (4)
Cat. No. Product Name Effect
Purity Phase
HY-P99444 Astegolimab Inhibitor 99.00% Phase 3
HY-P99673 Itepekimab Inhibitor 99.496% Phase 3
HY-P99872 Ecleralimab Inhibitor 97.35% Phase 2
HY-P991260 CNTO-6785 Inhibitor / Phase 2

Pre-clinical Phase

Bioactive Molecules (101)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-153040 HPPE Inhibitor 99.71% Unkown
HY-139206 LY3509754 Inhibitor 99.35% Unkown
HY-107046 UK-432097 Agonist 98.9% Unkown
HY-121246 Fluorofenidone Inhibitor 99.78% Unkown
HY-154795 Magnesium isoglycyrrhizinate hydrate Inhibitor 99.81% Unkown
HY-136239 Beclomethasone 17-propionate Agonist 99.52% Unkown
HY-120595 JNJ-49095397 Inhibitor 99.55% Unkown
HY-12463 Carmoterol hydrochloride Agonist 98.73% Unkown
HY-168973 Fexlamose Inhibitor 99.93% Unkown
HY-146346 HD-TAC7 Degrader 98.53% Unkown
HY-106929 Moxilubant Antagonist 99.83% Unkown
HY-W011085 CP-471474 Inhibitor 99.2% Unkown
HY-160928 Smurf1 modulator-1 Inhibitor 99.76% Unkown
HY-19830 AN3199 Inhibitor 99.76% Unkown
HY-111144 Abediterol Agonist 98.28% Unkown
HY-14190 Valategrast Antagonist 97.08% Unkown
HY-145390 Nrf2 activator-1 Activator 98.66% Unkown
HY-145390A (R,R)-Nrf2 activator-1 Activator 96.88% Unkown
HY-150579 Keap1-Nrf2-IN-13 Inhibitor 96.77% Unkown
HY-N2807 Acanthoside B Inhibitor 99.49% Unkown
HY-W744625 Olodaterol-d3 hydrochloride 99.9% Unkown
HY-176403 FPR1 antagonist 3 Antagonist 98.07% Unkown
HY-185463A β-Tryptase-IN-1 free base Inhibitor 98.0% Unkown
HY-159536 Frevecitinib Inhibitor 99.42% Unkown
HY-131910 IHMT-PI3Kδ-372 Inhibitor 99.69% Unkown
HY-111135 IKK2-IN-3 Inhibitor 98.0% Unkown
HY-120246 GS-5759 99.21% Unkown
HY-12093A (R)-MMP408 99.91% Unkown
HY-14296 PF-610355 Agonist / Unkown
HY-153192B (S)-Nerandomilast Inhibitor 98.69% Unkown
HY-B0010AS Formoterol-d3 Agonist 99.60% Unkown
HY-B0241S Ipratropium-d3 bromide Antagonist 98.0% Unkown
HY-119708S Ensifentrine-d6 Inhibitor 96.48% Unkown
HY-14190A (rac)-Valategrast / Unkown
HY-151198 CHF-6366 / Unkown
HY-162878 CHF-6523 Inhibitor / Unkown
HY-106006 RV-1729 Inhibitor / Unkown
HY-106293 ICI-200880 Inhibitor / Unkown
HY-106929B Moxilubant hydrochloride Antagonist / Unkown
HY-108644 SB 706504 Inhibitor / Unkown
HY-110268 NVP CXCR2 20 Antagonist / Unkown
HY-11072 MK-0359 Inhibitor / Unkown
HY-113749 L-Mabuterol hydrochloride Agonist / Unkown
HY-114052 NVP-ABE171 Inhibitor / Unkown
HY-117024 Abediterol napadisylate Agonist / Unkown
HY-119708A Ensifentrine tosylate Inhibitor / Unkown
HY-120322 MK-0969 Antagonist / Unkown
HY-123008 Reproterol hydrochloride / Unkown
HY-123461 Sul-121 hydrochloride Inhibitor / Unkown
HY-123862 LAS195319 Inhibitor / Unkown
HY-124270 Sibenadet hydrochloride Agonist / Unkown
HY-125050 KCA-1490 Inhibitor / Unkown
HY-125251 D159153 Inhibitor / Unkown
HY-126232 Verproside / Unkown
HY-12980A Batefenterol Succinate / Unkown
HY-130054 Theophylline L-lysine / Unkown
HY-131910A (R)-IHMT-PI3Kδ-372 Inhibitor 99.75% Unkown
HY-136705 MeO-Suc-Ala-Ala-Pro-Ala-CMK Inhibitor / Unkown
HY-14189 Valategrast hydrochloride Antagonist / Unkown
HY-142935 RORγt modulator 2 Modulator / Unkown
HY-142936 RORγt modulator 3 Modulator / Unkown
HY-143683S Theophylline-13C2,d6 / Unkown
HY-143723 SSAO inhibitor-3 Inhibitor / Unkown
HY-146974 PDE4-IN-9 Inhibitor / Unkown
HY-147518 p38-α MAPK-IN-5 Inhibitor / Unkown
HY-14786 Darotropium bromide Antagonist / Unkown
HY-148525 PF-4348235 / Unkown
HY-149235 PI3Kδ-IN-12 Inhibitor / Unkown
HY-15502 PF-3635659 Antagonist / Unkown
HY-155692 PDE4-IN-13 Inhibitor / Unkown
HY-157796 β2AR agonist 4 Agonist / Unkown
HY-163702 CHF-6550 / Unkown
HY-163982 FOXJ1 agonist 1 / Unkown
HY-165407 Neltenexine Inhibitor / Unkown
HY-167084A ASP9133 Antagonist / Unkown
HY-167891 GPD-1116 Inhibitor / Unkown
HY-174257 RCD405 Inhibitor / Unkown
HY-174426 LY104 / Unkown
HY-175432 p38 MAPK-IN-9 Inhibitor / Unkown
HY-176524S PDE3/4-IN-3 Inhibitor / Unkown
HY-178231 ALK5-IN-85 Inhibitor / Unkown
HY-179503 PDE/TRPA1/CHIT1-IN-1 Inhibitor / Unkown
HY-179504 PDE4B-IN-6 Inhibitor / Unkown
HY-180424 SYAF080 Antagonist / Unkown
HY-180792 CK-571 Inhibitor / Unkown
HY-B0241S1 Ipratropium-d7 bromide Antagonist / Unkown
HY-B0809S1 Theophylline-d3 / Unkown
HY-P10854 TAT-N15 Inhibitor / Unkown
HY-RS00891 ARCN1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W554021 S-Carboxymethyl-L-cysteine L-lysine monohydrate / Unkown
HY-W707640 Salbutamol-d4 / Unkown
HY-103167 CGH2466 dihydrochloride / Unkown
HY-119799 UK-500001 Inhibitor / Unkown
HY-121246S Fluorofenidone-d3 Inhibitor / Unkown
HY-14299C Indacaterol xinafoate Agonist / Unkown
HY-159686 Aclidinium Agonist / Unkown
HY-185463 β-Tryptase-IN-1 Inhibitor / Unkown
HY-D0205AS1 Carbocisteine-13C3-1 / Unkown
HY-D0205AS2 Carbocisteine-d3 / Unkown
HY-RS16316 COPD Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-U00352 PDE IV-IN-1 Inhibitor / Unkown
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P9923A Benralizumab (anti-IL5RA ) Inducer 99.60% Unkown